Ireland: Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
EU Council Adopts New EU Pharma Package
The Council of the EU has adopted the most comprehensive reform of EU pharmaceutical legislation in over 20 years, fundamentally reshaping regulatory protection mechanisms, market exclusivity periods, and incentive structures for pharmaceutical companies. These reforms balance patient access to medicines with creating a more competitive and innovation-friendly environment, addressing antimicrobial resistance, medicine supply challenges, and the early availability of generic alternatives.
Ireland Healthcare
M
Matheson
Article
Life Sciences Outlook 2026
Arthur Cox's Life Sciences Outlook 2026 examines critical regulatory developments and strategic opportunities shaping Ireland's life sciences sector. The publication explores Ireland's EU Council Presidency and its potential impact on advancing key legislative initiatives including the Biotech Act I and medical device reforms. Industry leaders will find comprehensive analysis spanning pharmaceutical compliance, medtech regulation, data governance, M&A activity, and environmental considerations.
Ireland Healthcare
AC
Arthur Cox
See more

Food and Drugs Law

Article
EU Council Adopts New EU Pharma Package
The Council of the EU has adopted the most comprehensive reform of EU pharmaceutical legislation in over 20 years, fundamentally reshaping regulatory protection mechanisms, market exclusivity periods, and incentive structures for pharmaceutical companies. These reforms balance patient access to medicines with creating a more competitive and innovation-friendly environment, addressing antimicrobial resistance, medicine supply challenges, and the early availability of generic alternatives.
Ireland Healthcare
M
Matheson
Article
Consultation Launched On Restricting Promotions Of HFSS Products In Northern Ireland
Northern Ireland's Food Standards Agency and Department of Health are consulting on new restrictions for promoting products high in fat, sugar and salt, aiming to align with UK-wide measures while grappling with which nutrient profiling model to adopt. The proposed regulations would limit volume price promotions, product placement in prominent retail locations, and free refill promotions for sugar-sweetened drinks, with enforcement handled by local councils.
Ireland Consumer
GA
Global Advertising Lawyers Alliance (GALA)
Article
Life Sciences Outlook 2026
Arthur Cox's Life Sciences Outlook 2026 examines critical regulatory developments and strategic opportunities shaping Ireland's life sciences sector. The publication explores Ireland's EU Council Presidency and its potential impact on advancing key legislative initiatives including the Biotech Act I and medical device reforms. Industry leaders will find comprehensive analysis spanning pharmaceutical compliance, medtech regulation, data governance, M&A activity, and environmental considerations.
Ireland Healthcare
AC
Arthur Cox
See more

Life Sciences, Biotechnology & Nanotechnology

Article
EU Council Adopts New EU Pharma Package
The Council of the EU has adopted the most comprehensive reform of EU pharmaceutical legislation in over 20 years, fundamentally reshaping regulatory protection mechanisms, market exclusivity periods, and incentive structures for pharmaceutical companies. These reforms balance patient access to medicines with creating a more competitive and innovation-friendly environment, addressing antimicrobial resistance, medicine supply challenges, and the early availability of generic alternatives.
Ireland Healthcare
M
Matheson
Article
Life Sciences Outlook 2026
Arthur Cox's Life Sciences Outlook 2026 examines critical regulatory developments and strategic opportunities shaping Ireland's life sciences sector. The publication explores Ireland's EU Council Presidency and its potential impact on advancing key legislative initiatives including the Biotech Act I and medical device reforms. Industry leaders will find comprehensive analysis spanning pharmaceutical compliance, medtech regulation, data governance, M&A activity, and environmental considerations.
Ireland Healthcare
AC
Arthur Cox
See more

Healthcare

Article
EU Council Adopts New EU Pharma Package
The Council of the EU has adopted the most comprehensive reform of EU pharmaceutical legislation in over 20 years, fundamentally reshaping regulatory protection mechanisms, market exclusivity periods, and incentive structures for pharmaceutical companies. These reforms balance patient access to medicines with creating a more competitive and innovation-friendly environment, addressing antimicrobial resistance, medicine supply challenges, and the early availability of generic alternatives.
Ireland Healthcare
M
Matheson
See more

Latest Videos

See more